Welcome to our dedicated page for West Pharm Svcs news (Ticker: WST), a resource for investors and traders seeking the latest updates and insights on West Pharm Svcs stock.
West Pharmaceutical Services (WST) delivers essential innovations in pharmaceutical packaging and injectable drug delivery systems. This page provides investors and industry professionals with timely updates on the company’s strategic developments, financial performance, and technological advancements.
Access authoritative reporting on WST’s earnings announcements, regulatory milestones, product launches, and global partnerships. Our curated news ensures you stay informed about critical developments in elastomer-based components, biologics containment, and self-injection device platforms.
Explore updates across key areas: quarterly financial results, manufacturing expansions, compliance achievements, and collaborations with healthcare leaders. Content is rigorously verified to support data-driven decisions while adhering to financial disclosure standards.
Bookmark this page for streamlined access to WST’s evolving role in advancing safe, efficient drug delivery solutions worldwide. Check regularly for unbiased insights into one of pharma packaging’s most innovative players.
West Pharmaceutical Services, Inc. (NYSE: WST) has been awarded the Heart of Pharma Award at the 2024 CPHI Awards for its partnership with Fox Chase Cancer Center. The award recognizes philanthropic, ethical, and community-based ventures. West has been a philanthropic partner of Fox Chase for over 20 years and pledged support for a next-generation mobile screening unit in 2021.
The new state-of-the-art mobile screening unit, sponsored by West, will provide services later this year, offering:
- Screening for more types of cancer
- 3D mammography
- Vaccine distribution
- Phlebotomy
- Collection of biospecimens and population data for cancer research
This initiative aims to increase access to cancer screenings in communities with healthcare access, demonstrating West's commitment to improving health and wellness in the communities they serve.
West Pharmaceutical Services (NYSE: WST) announced its participation at CPHI Worldwide in Milan, Italy, showcasing its leadership in packaging and containment solutions for injectable drug administration. The company will present on Contamination Control Strategy in Primary Packaging as part of EU GMP Annex 1 revisions, highlighting the critical role of quality control in drug manufacturing.
West is also a finalist for a CPHI Award in the 'Heart of Pharma' category for its partnership with Fox Chase Cancer Center, recognizing philanthropic and community-based initiatives. The awards ceremony will take place on October 8, the opening night of CPHI.
Cindy Reiss-Clark, Chief Commercial Officer at West, emphasized the importance of third-party suppliers' quality control in maintaining a robust contamination control strategy for drug manufacturers.
West Pharmaceutical Services (NYSE: WST) announced its participation in the Bank of America Global Healthcare Conference in London, UK. The event is scheduled for September 18, 2024, at 9:55 AM BST. As a global leader in injectable drug administration solutions, West's presentation at this conference is significant for investors and industry watchers.
The company will provide a live audio webcast of the event, accessible through the 'Investors' section of West's official website. For those unable to attend or watch live, a replay will be available for approximately 90 days after the event. This presentation offers an opportunity for stakeholders to gain insights into West's current operations, future strategies, and position in the healthcare industry.
West Pharmaceutical Services (NYSE: WST) reported Q2 2024 results with net sales of $702.1 million, down 6.9% year-over-year. Reported-diluted EPS was $1.51, compared to $2.06 in Q2 2023. The company updated its full-year 2024 guidance, lowering net sales expectations to $2.870-$2.900 billion from $3.000-$3.025 billion, and adjusted-diluted EPS to $6.35-$6.65 from $7.63-$7.88.
The Proprietary Products segment saw a 9.4% decline in net sales to $559.7 million, while the Contract-Manufactured Products segment grew by 4.9% to $142.4 million. Despite current challenges, management expects stronger revenues in the second half of 2024 and a return to organic growth in Q4 2024.
West Pharmaceutical Services (NYSE: WST) will release its second-quarter 2024 financial results on July 25, 2024, before the market opens. A conference call is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the results and business outlook. Interested participants must register in advance to receive the dial-in number and unique PIN for the call. The call will be accompanied by a slide presentation available on the company's website. A live audio webcast and subsequent replay will also be accessible in the 'Investors' section of the website, with the replay available for 30 days post-event.
West Pharmaceutical Services (NYSE: WST) has introduced Daikyo Crystal Zenith® (CZ) Nested Vials at the International Society for Cell and Gene Therapy Annual Meeting in Vancouver, Canada from May 29-June 1, 2024.
Designed to meet ISO 8362-1 standards, the vials are compatible with a range of aseptic fill-finish equipment. They offer features such as break resistance, low particulate specification, and low risk of chemical interaction.
Available in 2mL and 10mL sizes, the vials come with flexible closure options and are suitable for storing gene therapy drugs from preclinical to commercial phases. Chief Commercial Officer Cindy Reiss-Clark stated that this product expands CZ's platform for flexible filling solutions of sensitive molecules.
West Pharmaceutical Services (NYSE: WST) announced its participation in the William Blair 44th Annual Growth Stock Conference in Chicago, IL, on June 4, 2024, at 8:00 AM CT. The event will feature a live audio webcast available on the company's website, www.westpharma.com, in the 'Investors' section. The webcast replay will be accessible for 90 days post-event.
West Pharmaceutical Services, Inc. (NYSE: WST) will participate in the Bank of America Securities Healthcare Conference in Las Vegas, NV on May 14, 2024. The company will present at 11:20 AM PT and offer a live audio webcast on their website. Investors can access the webcast on www.westpharma.com.
FAQ
What is the current stock price of West Pharm Svcs (WST)?
What is the market cap of West Pharm Svcs (WST)?
